Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season

Causing millions of cases worldwide every year, influenza is one of the most common respiratory infections. The effectiveness of influenza vaccination and the nature of the resulting immune response may vary depending on the vaccine composition and age group. Since children are at the highest risk o...

Full description

Bibliographic Details
Main Authors: Zh. V. Buzitskaya, A. B. Popov, E. A. Romanovskaya-Romanko, M. V. Sergeeva, E. A. Varyushina, M. K. Erofeeva, M. A. Stukova, D. A. Lioznov
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2023-06-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/2737
_version_ 1797197840128147456
author Zh. V. Buzitskaya
A. B. Popov
E. A. Romanovskaya-Romanko
M. V. Sergeeva
E. A. Varyushina
M. K. Erofeeva
M. A. Stukova
D. A. Lioznov
author_facet Zh. V. Buzitskaya
A. B. Popov
E. A. Romanovskaya-Romanko
M. V. Sergeeva
E. A. Varyushina
M. K. Erofeeva
M. A. Stukova
D. A. Lioznov
author_sort Zh. V. Buzitskaya
collection DOAJ
description Causing millions of cases worldwide every year, influenza is one of the most common respiratory infections. The effectiveness of influenza vaccination and the nature of the resulting immune response may vary depending on the vaccine composition and age group. Since children are at the highest risk of disease and act as the main carriers of influenza, the assessment of the immunological efficacy of vaccines in this group is crucial for controlling the epidemic. Therefore, this study aimed to evaluate the characteristics of the humoral immune response in children after immunization with various types of inactivated influenza vaccines. An observational study was conducted in the 2019-2020 season and involved 230 children (< 18 years old) and a comparison group of 87 adults aged 18 to 60 years. The subjects, who provided informed consent to participate, were vaccinated with one of three vaccines (Grippol Plus, Sovigripp, or Ultrix) in an open-label fashion. The humoral immune response was assessed by measuring the hemagglutination inhibition (HI) titer in the paired sera taken before and three weeks after vaccination. The immunogenicity of the vaccines in the age group under 18, met the CPMP criteria for the assessment of inactivated influenza vaccines in terms of the fold increase in antibody titers and the proportion of individuals with seroconversion to all three components (A/H1N1pdm09, A/H3N2, and B/Victoria). Although 6 to 18-year-old participants showed a more robust immune response to the B/Victoria component compared to the adult participants (aged 18 to 60), it was insufficient to ensure that 70% of the participants have a protective antibody titer. A comparative analysis of the vaccines’ immunogenicity was carried out for a subgroup of children aged 6-18 who had initially low antibody levels at the time of vaccination. The analysis showed that the split vaccine Ultrix outperformed the adjuvanted vaccine Grippol Plus in generating an antibody response to the component B/Victoria; however, the antibody responses to the A/H1N1pdm09 and A/H3N2 components did not differ between the two vaccines. The children under 6 years of age demonstrated a less pronounced humoral immune response to vaccination compared with the other age groups, which may be due to the age-related characteristics of the immune system in children of preschool age.
first_indexed 2024-03-08T05:47:02Z
format Article
id doaj.art-c951c9d7c1764b95a6f9bc3af7ae1ba8
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2024-04-24T06:50:21Z
publishDate 2023-06-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-c951c9d7c1764b95a6f9bc3af7ae1ba82024-04-22T13:07:50ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2023-06-0125475175810.15789/1563-0625-AOT-27371705Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 seasonZh. V. Buzitskaya0A. B. Popov1E. A. Romanovskaya-Romanko2M. V. Sergeeva3E. A. Varyushina4M. K. Erofeeva5M. A. Stukova6D. A. Lioznov7A. Smorodintsev Research Institute of InfluenzaA. Smorodintsev Research Institute of InfluenzaA. Smorodintsev Research Institute of InfluenzaA. Smorodintsev Research Institute of InfluenzaA. Smorodintsev Research Institute of InfluenzaA. Smorodintsev Research Institute of InfluenzaA. Smorodintsev Research Institute of InfluenzaA. Smorodintsev Research Institute of Influenza; First St. Petersburg State I. Pavlov Medical UniversityCausing millions of cases worldwide every year, influenza is one of the most common respiratory infections. The effectiveness of influenza vaccination and the nature of the resulting immune response may vary depending on the vaccine composition and age group. Since children are at the highest risk of disease and act as the main carriers of influenza, the assessment of the immunological efficacy of vaccines in this group is crucial for controlling the epidemic. Therefore, this study aimed to evaluate the characteristics of the humoral immune response in children after immunization with various types of inactivated influenza vaccines. An observational study was conducted in the 2019-2020 season and involved 230 children (< 18 years old) and a comparison group of 87 adults aged 18 to 60 years. The subjects, who provided informed consent to participate, were vaccinated with one of three vaccines (Grippol Plus, Sovigripp, or Ultrix) in an open-label fashion. The humoral immune response was assessed by measuring the hemagglutination inhibition (HI) titer in the paired sera taken before and three weeks after vaccination. The immunogenicity of the vaccines in the age group under 18, met the CPMP criteria for the assessment of inactivated influenza vaccines in terms of the fold increase in antibody titers and the proportion of individuals with seroconversion to all three components (A/H1N1pdm09, A/H3N2, and B/Victoria). Although 6 to 18-year-old participants showed a more robust immune response to the B/Victoria component compared to the adult participants (aged 18 to 60), it was insufficient to ensure that 70% of the participants have a protective antibody titer. A comparative analysis of the vaccines’ immunogenicity was carried out for a subgroup of children aged 6-18 who had initially low antibody levels at the time of vaccination. The analysis showed that the split vaccine Ultrix outperformed the adjuvanted vaccine Grippol Plus in generating an antibody response to the component B/Victoria; however, the antibody responses to the A/H1N1pdm09 and A/H3N2 components did not differ between the two vaccines. The children under 6 years of age demonstrated a less pronounced humoral immune response to vaccination compared with the other age groups, which may be due to the age-related characteristics of the immune system in children of preschool age.https://www.mimmun.ru/mimmun/article/view/2737inactivated influenza vaccinechildrenadolescentsantibodieshemagglutination inhibition reactionimmunogenicity criteria
spellingShingle Zh. V. Buzitskaya
A. B. Popov
E. A. Romanovskaya-Romanko
M. V. Sergeeva
E. A. Varyushina
M. K. Erofeeva
M. A. Stukova
D. A. Lioznov
Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season
Медицинская иммунология
inactivated influenza vaccine
children
adolescents
antibodies
hemagglutination inhibition reaction
immunogenicity criteria
title Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season
title_full Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season
title_fullStr Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season
title_full_unstemmed Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season
title_short Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season
title_sort assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019 2020 season
topic inactivated influenza vaccine
children
adolescents
antibodies
hemagglutination inhibition reaction
immunogenicity criteria
url https://www.mimmun.ru/mimmun/article/view/2737
work_keys_str_mv AT zhvbuzitskaya assessmentofthehumoralimmuneresponseinchildrenafterimmunizationwithdifferenttypesofinactivatedinfluenzavaccinesinthe20192020season
AT abpopov assessmentofthehumoralimmuneresponseinchildrenafterimmunizationwithdifferenttypesofinactivatedinfluenzavaccinesinthe20192020season
AT earomanovskayaromanko assessmentofthehumoralimmuneresponseinchildrenafterimmunizationwithdifferenttypesofinactivatedinfluenzavaccinesinthe20192020season
AT mvsergeeva assessmentofthehumoralimmuneresponseinchildrenafterimmunizationwithdifferenttypesofinactivatedinfluenzavaccinesinthe20192020season
AT eavaryushina assessmentofthehumoralimmuneresponseinchildrenafterimmunizationwithdifferenttypesofinactivatedinfluenzavaccinesinthe20192020season
AT mkerofeeva assessmentofthehumoralimmuneresponseinchildrenafterimmunizationwithdifferenttypesofinactivatedinfluenzavaccinesinthe20192020season
AT mastukova assessmentofthehumoralimmuneresponseinchildrenafterimmunizationwithdifferenttypesofinactivatedinfluenzavaccinesinthe20192020season
AT dalioznov assessmentofthehumoralimmuneresponseinchildrenafterimmunizationwithdifferenttypesofinactivatedinfluenzavaccinesinthe20192020season